In 2020, 19 million new cases of cancer were identified all over the world, according to the World Health Organization.
It is the second most common cause of death globally.
The most common treatment is chemotherapy. But it is limited by its non-specificity since it targets all actively dividing cells, including healthy cells.
Chemotherapy leads to heavy side effects on the patients.
CALIPSO IS THE SOLUTION
We developed a liposomal drug delivery system combining advanced liposomes and synthetic biology.
The idea is to use liposomes to specifically deliver an anticancer drug directly produced next to cancer cells, to limit side effects.
